Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 11.9B | 10.9B | 10.8B | 10.5B |
Cost of revenue | 2.7B | 2.6B | 2.7B | 2.6B |
Gross profit | 9.2B | 8.3B | 8.2B | 8.0B |
Operating expense | ||||
Research & development | 2.2B | 1.9B | 2.3B | 1.9B |
Selling general and admin | 2.8B | 2.4B | 2.8B | 2.5B |
Other operating expenses | 384.8M | 244.8M | 288.8M | 628.0M |
Operating income | 3.9B | 3.7B | 2.8B | 2.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 231.2M | 216.0M | 220.0M | 211.2M |
Other income expense | -2.4M | -2.4M | -146.4M | -3.2M |
Pretax income | 3.6B | 3.5B | 2.6B | 2.7B |
Tax provision | 405.6M | 638.4M | 372.0M | 160.0M |
Net income | 3.2B | 2.9B | 2.3B | 2.5B |
Basic EPS | 2.1 | 1.8 | 1.4 | 1.6 |
Diluted EPS | 2.1 | 1.8 | 1.4 | 1.6 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 4.9B | 4.7B | 4.2B | 4.5B |
Net income from continuing op. | 3.2B | 2.9B | 2.3B | 2.5B |
Minority interests | 13.6M | -2.4M | -1.6M | 3.2M |
Preferred stock dividends | — | — | — | — |